Francesca Carlomagno
University of Naples Federico II(IT)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Cancer-related Molecular Pathways, HER2/EGFR in Cancer Research, Microtubule and mitosis dynamics, Wnt/β-catenin signaling in development and cancer
Most-Cited Works
- → Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B(1995)836 cited
- ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.(2002)
- → BAY 43-9006 Inhibition of Oncogenic RET Mutants(2006)471 cited
- → Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.(1992)392 cited
- Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.(2003)
- RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.(1998)
- → Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors(2004)253 cited
- →